• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于氢键网络调控的分子修饰新型羰基还原酶高效合成 Vibegron 中间体

Efficient biosynthesis of Vibegron intermediate using a novel carbonyl reductase based on molecular modification of hydrogen bonding network regulation.

机构信息

National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, Zhejiang University of Technology, Hangzhou 310014, People's Republic of China; Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, People's Republic of China.

National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, Zhejiang University of Technology, Hangzhou 310014, People's Republic of China; Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, People's Republic of China.

出版信息

Bioorg Chem. 2023 Nov;140:106788. doi: 10.1016/j.bioorg.2023.106788. Epub 2023 Aug 14.

DOI:10.1016/j.bioorg.2023.106788
PMID:37598433
Abstract

Vibegron is a novel, potent, highly selective β-adrenergic receptor agonist for the treatment of overactive bladder with higher therapeutic capacity and lower side effects. Methyl(2S,3R)-2-((tert-butoxycarbonyl)amino)-3-hydroxy-3-phenylpropanoate ((2S,3R)-aminohydroxy ester) is a key chiral intermediate for the synthesis of Vibegron. A novel carbonyl reductase from Exiguobacterium sp. s126 (EaSDR6) was isolated using data mining technology from GenBank database with preferable catalytic activity. Hydrogen bond network regulation was performed using site-directed saturation mutagenesis and combination mutagenesis. The mutant EaSDR6 was obtained with the activity improvement by 4.58 folds compared with the wild type EaSDR6. The K of EaSDR6 was decreased from 1.57 mM to 0.67 mM, k was increased by 2.17 folds, and the overall catalytic efficiency k/K was increased by 5.07 folds. The organic-aqueous biphasic bioreaction system for the asymmetric synthesis of (2S,3R)-aminohydroxy ester was constructed for the first time. Under the substrate concentration of 150 g/L, the yield of (2S,3R)-aminohydroxy ester was > 99.99%, the e.e. was > 99.99%, and the spatiotemporal yield was 1.55 g/(L·h·g ) after 12 h reaction. While the substrate concentration was increased to 200 g/L and the reaction lasted for 36 h, the yield of (2S,3R)-aminohydroxy ester was > 99.99%, the e.e. was > 99.99% and the spatiotemporal yield was 1.05 g/(L·h·g ). The substrate concentration and spatiotemporal yield were higher than ever reported.

摘要

Vibegron 是一种新型、高效、高选择性的β-肾上腺素能受体激动剂,用于治疗膀胱过度活动症,具有更高的治疗效果和更低的副作用。(2S,3R)-2-((叔丁氧基羰基)氨基)-3-羟基-3-苯基丙酸甲酯((2S,3R)-氨基羟酯)是 Vibegron 合成的关键手性中间体。利用 GenBank 数据库中的数据挖掘技术,从极端微生物 Exiguobacterium sp. s126 中分离到一种新型的羰基还原酶(EaSDR6),其具有较好的催化活性。通过定点饱和突变和组合突变进行氢键网络调控。与野生型 EaSDR6 相比,突变体 EaSDR6 的活性提高了 4.58 倍。EaSDR6 的 K 值从 1.57mM 降低到 0.67mM,k 值提高了 2.17 倍,总催化效率 k/K 提高了 5.07 倍。首次构建了用于(2S,3R)-氨基羟酯不对称合成的有机-水两相生物反应体系。在底物浓度为 150g/L 的条件下,(2S,3R)-氨基羟酯的产率>99.99%,ee 值>99.99%,时空产率为 1.55g/(L·h·g),反应 12h 后。当底物浓度增加到 200g/L,反应持续 36h 时,(2S,3R)-氨基羟酯的产率>99.99%,ee 值>99.99%,时空产率为 1.05g/(L·h·g)。底物浓度和时空产率均高于以往报道。

相似文献

1
Efficient biosynthesis of Vibegron intermediate using a novel carbonyl reductase based on molecular modification of hydrogen bonding network regulation.基于氢键网络调控的分子修饰新型羰基还原酶高效合成 Vibegron 中间体
Bioorg Chem. 2023 Nov;140:106788. doi: 10.1016/j.bioorg.2023.106788. Epub 2023 Aug 14.
2
Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder.新型β3肾上腺素能激动剂维贝格隆的药理学特性:对膀胱过度活动症联合治疗中抗毒蕈碱受体选择性的评估
J Pharmacol Exp Ther. 2017 Feb;360(2):346-355. doi: 10.1124/jpet.116.237313. Epub 2016 Dec 13.
3
Production of tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate using carbonyl reductase coupled with glucose dehydrogenase with high space-time yield.使用羰基还原酶与葡萄糖脱氢酶偶联,以高产时空收率生产叔丁基 (3R,5S)-6-氯-3,5-二羟基己酸酯。
Biotechnol Prog. 2020 Jan;36(1):e2900. doi: 10.1002/btpr.2900. Epub 2019 Sep 12.
4
Large-scale synthesis of tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate by a stereoselective carbonyl reductase with high substrate concentration and product yield.通过具有高底物浓度和产物收率的立体选择性羰基还原酶大规模合成叔丁基(3R,5S)-6-氯-3,5-二羟基己酸酯。
Biotechnol Prog. 2017 May;33(3):612-620. doi: 10.1002/btpr.2460. Epub 2017 Mar 24.
5
Directed Evolution of Carbonyl Reductase from Rhodosporidium toruloides and Its Application in Stereoselective Synthesis of tert-Butyl (3R,5S)-6-Chloro-3,5-dihydroxyhexanoate.来源于粘红酵母的羰基还原酶的定向进化及其在手性选择性合成叔丁基 (3R,5S)-6-氯-3,5-二羟基己酸酯中的应用。
J Agric Food Chem. 2017 May 10;65(18):3721-3729. doi: 10.1021/acs.jafc.7b00866. Epub 2017 May 1.
6
Biosynthesis of tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate by carbonyl reductase from Rhodosporidium toruloides in mono and biphasic media.利用从粘红酵母中提取的羰基还原酶在单相和双相介质中合成叔丁基(3R,5S)-6-氯-3,5-二羟基己酸酯。
Bioresour Technol. 2018 Feb;249:161-167. doi: 10.1016/j.biortech.2017.09.204. Epub 2017 Oct 5.
7
Additive effects of intravenous and intravesical application of vibegron, a β-adrenoceptor agonist, on bladder function in rats with bladder overactivity.静脉和膀胱内给予β肾上腺素受体激动剂维贝格隆对膀胱过度活动大鼠膀胱功能的叠加作用。
Naunyn Schmiedebergs Arch Pharmacol. 2020 Nov;393(11):2073-2080. doi: 10.1007/s00210-020-01921-2. Epub 2020 Jun 18.
8
Synthesis of Vibegron Enabled by a Ketoreductase Rationally Designed for High pH Dynamic Kinetic Reduction.酮还原酶的合理设计实现了 Vibegron 的高 pH 动力学还原合成。
Angew Chem Int Ed Engl. 2018 Jun 4;57(23):6863-6867. doi: 10.1002/anie.201802791. Epub 2018 May 3.
9
Vibegron for the treatment of overactive bladder: a comprehensive update.卫喜康(盐酸戊乙奎醚)治疗膀胱过度活动症:全面更新。
Expert Opin Pharmacother. 2022 Sep;23(13):1479-1484. doi: 10.1080/14656566.2022.2126311. Epub 2022 Sep 21.
10
Efficient production of an ezetimibe intermediate using carbonyl reductase coupled with glucose dehydrogenase.利用羰基还原酶与葡萄糖脱氢酶高效生产依折麦布中间体。
Biotechnol Prog. 2021 Jan;37(1):e3068. doi: 10.1002/btpr.3068. Epub 2020 Sep 14.

引用本文的文献

1
Modification of carbonyl reductase based on substrate pocket loop regions alteration: an application for synthesis of duloxetine chiral intermediate in high efficiency.基于底物口袋环区改造的羰基还原酶修饰:在高效合成度洛西汀手性中间体中的应用
Bioprocess Biosyst Eng. 2025 Jun;48(6):927-937. doi: 10.1007/s00449-025-03152-2. Epub 2025 Apr 29.